Dr. Sheikh was the UNC Principal Investigator for this study, which was conducted at UNC’s Clinical & Translational Research Center (CTRC), a resource through NC TraCS.
You can access the story via this link: Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus | NEJM.